Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

(2013) Francesco Lo-Coco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia

(2011) E Lengfelder et al.   LEUKEMIA

The Cardiac Safety Research Consortium electrocardiogram warehouse: Thorough QT database specifications and principles of use for algorithm development and testing

(2010) Paul Kligfield et al.   AMERICAN HEART JOURNAL

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710

(2010) B. L. Powell et al.   BLOOD

Prevention of Torsade de Pointes in Hospital Settings

(2010) Barbara J. Drew et al.   CIRCULATION

Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome

(2010) Gail J. Roboz et al.   LEUKEMIA RESEARCH

Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

(2008) Gail J. Roboz et al.   CANCER

Accurately measured and properly heart-rate corrected QTc intervals show little daytime variability

(2008) Marek Malik et al.   HEART RHYTHM